Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
MinuteCE®
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
MinuteCE®
From Risk to Results: Cases in ASCVD Prevention and Treatment
1.00 credit 10 episodes
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit 10 episodes
When and Why to Use CAC Scoring
When and Why to Use CAC Scoring
MinuteCE®
When and Why to Use CAC Scoring
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Statins and Safety: What the Data Say About Dementia, Cancer, and More
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®
Statins and Safety: What the Data Say About Dementia, Cancer, and More
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
MinuteCE®
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Albuminuria Change and Finerenone's Effect on CV Outcomes
Albuminuria Change and Finerenone's Effect on CV Outcomes
CME/CE
Albuminuria Change and Finerenone's Effect on CV Outcomes
- Finnian R. McCausland, MD
Topline Results of the CONFIDENCE Trial
Topline Results of the CONFIDENCE Trial
CME/CE
Topline Results of the CONFIDENCE Trial
- Rajiv Agarwal, MBBS, MD, FASN, BRCU

Programs

Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
MinuteCE®
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Bridging ASCVD Care Between Academic and Rural Settings
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®
Bridging ASCVD Care Between Academic and Rural Settings
1.00 program credit
- Rishi Wadhera, MD, MPP, Mphil
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
1.00 program credit
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
CME/CE
Impact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
- Finnian R. McCausland, MD
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CE
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
0.25 credits
- prof. Hiddo Heerspink
- Jennifer B. Green, MD
0.25 credits
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart Matters
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
- Michelle Kittleson, MD, PhD

Clinical Practice

Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
MinuteCE®
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
1.00 program credit
- Rishi Wadhera, MD, MPP, Mphil
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
1.00 program credit
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
- John Ostrominski
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
- Akshay S. Desai, MD
NYHA FC and Finerenone Response: Clinical Trial Insights
NYHA FC and Finerenone Response: Clinical Trial Insights
Cardiology
NYHA FC and Finerenone Response: Clinical Trial Insights
- John Ostrominski
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Cardiology
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
- Akshay S. Desai, MD
Implementing the SOC Induction Therapies in AAV 
Implementing the SOC Induction Therapies in AAV 
MinuteCE®
Implementing the SOC Induction Therapies in AAV 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Bernhard Hellmich, MD
0.75 program credits
Optimizing AAV Outcomes: Maintenance Therapies
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®
Optimizing AAV Outcomes: Maintenance Therapies
0.75 program credits
- Bernhard Hellmich, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 program credits

CME

Target in Sight: Escalating Therapy to Reach LDL-C Goals
Target in Sight: Escalating Therapy to Reach LDL-C Goals
MinuteCE®
Target in Sight: Escalating Therapy to Reach LDL-C Goals
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
- Piotr Ponikowski, MD, PhD, FESC, FHFA
0.25 credits
Don't Miss It! Rapid & Accurate AAV Diagnosis 
Don't Miss It! Rapid & Accurate AAV Diagnosis 
MinuteCE®
Don't Miss It! Rapid & Accurate AAV Diagnosis 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Elevating Care for Patients With Severe Renal Disease in AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®
Elevating Care for Patients With Severe Renal Disease in AAV
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Patient Case Study: Elderly
Patient Case Study: Elderly
MinuteCE®
Patient Case Study: Elderly
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Obesity
Patient Case Study: Obesity
MinuteCE®
Patient Case Study: Obesity
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Setting the Stage of Real-World Data vs RCT
Setting the Stage of Real-World Data vs RCT
MinuteCE®
Setting the Stage of Real-World Data vs RCT
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit